Elanco Animal Health Incorporated Unrecognized Tax Benefits that Would Impact Effective Tax Rate
Elanco Animal Health Incorporated (ELAN) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $2.00 million as of 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2023-03-01
- 2022-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $2.00M.
- 2021-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $6.00M.
- 2020-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $3.00M; Unrecognized Tax Benefits that Would Impact Effective Tax Rate as first filed $2.50M.
- 2019-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $8.20M.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate as first filed |
|---|---|---|
| 2022-12-31 | $2.00M 10-K · filed 2023-03-01 | |
| 2021-12-31 | $6.00M 10-K · filed 2023-03-01 | |
| 2020-12-31 | $3.00M 10-K · filed 2023-03-01 | $2.50M 10-K · filed 2021-03-01 |
| 2019-12-31 | $8.20M 10-K · filed 2021-03-01 | |
| 2018-12-31 | $12.80M 10-K · filed 2020-02-28 | |
| 2017-12-31 | $29.60M 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |